# Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC

> **NCT04984148** · — · UNKNOWN · sponsor: **Guangdong Provincial People's Hospital** · enrollment: 70 (estimated)

## Conditions studied

- Stage III Non-small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** CT

## Key facts

- **NCT ID:** NCT04984148
- **Lead sponsor:** Guangdong Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2024-01-31
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2021-11-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04984148

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04984148, "Construction of CT Radiomics Model for Predicting the Efficacy of Immunotherapy in Patients With Stage III NSCLC". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04984148. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*